APAC CIOOutlook

Advertise

with us

  • Technologies
      • Artificial Intelligence
      • Big Data
      • Blockchain
      • Cloud
      • Digital Transformation
      • Internet of Things
      • Low Code No Code
      • MarTech
      • Mobile Application
      • Security
      • Software Testing
      • Wireless
  • Industries
      • E-Commerce
      • Education
      • Logistics
      • Retail
      • Supply Chain
      • Travel and Hospitality
  • Platforms
      • Microsoft
      • Salesforce
      • SAP
  • Solutions
      • Business Intelligence
      • Cognitive
      • Contact Center
      • CRM
      • Cyber Security
      • Data Center
      • Gamification
      • Procurement
      • Smart City
      • Workflow
  • Home
  • CXO Insights
  • CIO Views
  • Vendors
  • News
  • Conferences
  • Whitepapers
  • Newsletter
  • Awards
Apac
  • Artificial Intelligence

    Big Data

    Blockchain

    Cloud

    Digital Transformation

    Internet of Things

    Low Code No Code

    MarTech

    Mobile Application

    Security

    Software Testing

    Wireless

  • E-Commerce

    Education

    Logistics

    Retail

    Supply Chain

    Travel and Hospitality

  • Microsoft

    Salesforce

    SAP

  • Business Intelligence

    Cognitive

    Contact Center

    CRM

    Cyber Security

    Data Center

    Gamification

    Procurement

    Smart City

    Workflow

Menu
    • Biotech
    • Cyber Security
    • Hotel Management
    • Workflow
    • E-Commerce
    • Business Intelligence
    • MORE
    #

    Apac CIOOutlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIOOutlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    Editor's Pick (1 - 4 )
    left
    Framework of Three Horizons to Manage Current and Future Growth

    Clark Golestani, VP & CIO, Merck

    The Changing Role of CIO in the Biopharmaceutical Industry

    Andy Newsom, CIO, CSL Behring

    Formula Five For Biotech IT

    Jeffrey Keisling, CIO and SVP, Pfizer

    Finding Answers in R&D Data is a Team Sport

    Dan Hausman,

    Plant Biotechnology Success Requires Collaboration, Proactive Strategy

    Tim Hassinger, President and CEO, Dow AgroSciences

    The Biotech IT PMO 2.0

    Paul Ritchie,

    The Internet of Things in Healthcare:Smart Strategies to Deliver Better Value

    Miguel Louzan, VP-IT, UCB, Inc.

    right

    The Biotech CIO Roadmap in a Sea of Change

    Amit Shah, VP of IT- Enterprise Applications & Systems, Excelitas Technologies

    Tweet
    content-image

    Amit Shah, VP of IT- Enterprise Applications & Systems, Excelitas Technologies

    Anyone with their finger on the pulse of the biotechnology industry today will tell you that Biotech is going through a virtual tsunami of change through mergers and acquisi­tions that are shaking the very foundation of some of the biggest companies and institutions in the field. When you consider that in 2014 alone there has been Biotech M&A deals in excess of $100 billion, it’s clear that we have reached a true watershed moment for the industry. As Biotech is rapidly evolving, and so the role, re­sponsibility and the intrinsic value of the Biotech CIO.

    The biotech CIO is increasingly being called upon to “come out from the back room of IT” and help guide companies through peri­ods of transition. As such, biotech CIOs today sit at the intersection of the company’s C-suite leadership, the legacy systems of old and the disruptive technologies of the present and future including big data, cloud, social, mobility and artificial intelligence. Bringing all of these elements into harmony and efficiency can make the difference between a successful biotech M&A and enterprise-wide dysfunction.

    But despite the challenges posed by the M&A transaction pro­cess and the post-transaction integration, there is a path forward. As an IT VP for a global technology leader with deep roots in the Biotech , I’ve seen suc­cesses and failures in M&A’s and would like to offer my thoughts on what I call the Biotech CIO Roadmap for M&A Success.

    As with many long journeys, the best place to start is by asking the right questions at the outset.

    • What are the main business objectives for the merger or acquisition?
    • How can IT integration be leveraged as an opportunity to help reach those objectives and position the company for growth?
    • How can synergy between systems and cultures be estab­lished short term and long term?
    • What kind of tailored approach to IT integration is needed to obtain that synergy?
    • What are the key personnel gaps that stand in the way and how can they be addressed?

    The answers to these important questions will help chart the course, but before proceeding with full culture and sys­tem integration during a merger or acquisition, a healthy amount of due diligence is also required. This early stage requires a strong focus on the risks associated with synergy and the uncertainties and variables that prove inevitable with every merger or acquisition. The bottom line is that IT due diligence should result in a broader understanding of the risk profile for IT integration, a clear migration plan and a defini­tive synergy timeline.

    “Every IT staff, post-merger or acquisition, will have its own unique strengths and weaknesses. The role of the CIO is to evaluate the team and reorganize throughout phase one and two as needed to optimize talent”

    Moving forward, the process of

    the actual post-merger or acquisition integration must go through two distinct phases and a consistent mindset throughout with regular assessment and evaluation along the way. It’s critical to recognize the truth that every company or institution is unique and brings with it a distinctive culture, attributes and vices – all of which require a specialized approach. There are however, some universal processes that I believe should be implemented to achieve success.

    Phase One encom­passes the first 90 to 180 days of the post-merger or acquisition. The key guid­ing principles that I believe can lead to successful progress dur­ing this crucial time include the following.

    People First, Process Second. Listen – really listen - to all key stakeholders involved in the process and establish an envi­ronment of true collaboration. Learn the history behind key de­cisions that others have made in the past with relation to biotech IT processes before making changes to the status quo. Interface regularly with other parts of the organization such as HR and finance to ensure change management is well organized. And always remember, you are not just merging companies, but cul­tures and every company or institution culture has positive con­tributions to make.

    Avoid Disruptions to Business Operations. No matter what, a successful merger or acquisition process is one that does not hinder the business itself, so it is critical to avoid distractions to business activities and not change the behavior of transaction processing systems such as ERP and SCM etc.

    Infusion. Inside and Out. In addition to key infrastructure integrations that are essential such as WAN, email systems and financial reporting systems, it’s also crucial to present a unified face to the outside world including both vendor management but also with regard to the brand identity itself of the new company including the website and all public facing brand assets and mar­keting materials.

    In Phase Two it now falls upon the biotech CIO to look across the enterprise over the next one to two years post-merger or acquisition with a wide angle lens to evaluate and re-evaluate all aspects of the IT integration and applications used by all various lines of businesses, functional organizations and corpo­rate at-large and to advise the C-level on where im­provements can be made. I like to put these evaluations into a series of categories.

    Consolidation. Which systems and applica­tions from one company – such as EPM or ERP - can be converted to the other company system to improve operational efficiency?

    Amalgamation. What sys­tems and applications can be combined to form a “new” unit to operate the com­bined entity?

    Preservation. Which systems and applications are so essentially unique to a business unit’s capabilities and cul­ture that they need to be maintained  Retirement. Where are the redundancies and what systems are no longer necessary to drive enterprise efficiency?

    Throughout both of these critical phases, it is incumbent upon the biotech CIO to keep a laser-like focus on what I call “The Three Ps” – People, Process and Projects.

    Every IT staff, post-merger or acquisition, will have its own unique strengths and weaknesses. The role of the CIO is to eval­uate the team and reorganize throughout phase one and two as needed to optimize talent. These can be times of great internal tension and stress, so as reorganization evolves, it is incum­bent upon the CIO to communicate effectively about every change and emphasize not only the “what,” but the “why.”

    Key processes such as project management, spending approvals and company trainings among others must be harmonized – again taking the best from both of the companies or institutions.

    Finally, it is critical that key company personnel become invested in each phase of the process. Desig­nate project managers to coordinate various elements of the integration within IT and from a broader enterprise perspective as well. It’s also important to emphasize the need for speed in execution because the longer the merger or acquisition integration takes, the higher the risk for the company in meeting synergy goals.

    As we all know, the only constant is change and today this has never been truer than for the biotechnology industry. But with change comes opportunity. The enhanced role of the CIO within the enterprise – and the higher level of influence it provides – gives biotech CIO’s a unique opportunity to help their companies navigate this sea of change and sail on to future success.

    Check Out : TOP BIOTECH STARTUPS IN APAC
    tag

    Startups

    Biotechnology

    Big Data

    Financial

    HR

    Weekly Brief

    loading
    ON THE DECK

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    Modernizing Lending Through Innovative, Secure and Scalable Technology

    Modernizing Lending Through Innovative, Secure and Scalable Technology

    Steven Meek, Chief Information Officer, Pepper Money
    Advancing the Chemical Industry through Digital Transformation

    Advancing the Chemical Industry through Digital Transformation

    Jan Mandrup Olesen, Global Head of Digital Business, Indorama Ventures
    Cultivating a Sustainable Future through Collaboration

    Cultivating a Sustainable Future through Collaboration

    Jiunn Shih, Chief Marketing, Innovation & Sustainability Officer, Zespri International
    Mastering Digital Marketing Strategies

    Mastering Digital Marketing Strategies

    Tasya Aulia, Director of Marketing and Communications, Meliá Hotels International
    Building a Strong Collaborative Framework for Artificial Intelligence

    Building a Strong Collaborative Framework for Artificial Intelligence

    Boon Siew Han, Regional Head of Humanoid Component Business & R&D (Apac & Greater China), Schaeffler
    From Legacy to Agility Through Digital Transformation

    From Legacy to Agility Through Digital Transformation

    Athikom Kanchanavibhu, EVP, Digital & Technology Transformation, Mitr Phol Group
    Change Management for Clinical Ancillary Teams: Aligning Practice with Policy and Progress

    Change Management for Clinical Ancillary Teams: Aligning Practice with Policy and Progress

    Ts. Dr. James Chong, Chief Executive Officer, Columbia Asia Hospital – Tebrau
    Digital Transformation: A Journey Beyond Technology

    Digital Transformation: A Journey Beyond Technology

    John Ang, Group CTO, EtonHouse International Education Group
    Loading...
    Copyright © 2025 APAC CIOOutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    Home |  CXO Insights |   Whitepapers |   Subscribe |   Conferences |   Sitemaps |   About us |   Advertise with us |   Editorial Policy |   Feedback Policy |  

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://biotech.apacciooutlook.com/cxoinsights/the-biotech-cio-roadmap-in-a-sea-of-change-nwid-1552.html